Drug details

Namenda XR (memantine hydrochloride extended release capsules)

type of NMDA Antagonists

Namenda XR (memantine hydrochloride) Extended Release is an NMDA receptor antagonist used to treat moderate to severe dementia of the Alzheimer's type.

The drug is often used to treat Dementia .

This drug may have the following side effects:

• nausea,
• headache,
• dizziness,
• vomiting,
• diarrhea,
• constipation,
• skin rash,
• joint pain,
• loss of appetite,
• drowsiness,
• anxiety,
• back pain,
• abdominal pain,
• tired feeling,
• fast heart rate,
• easy bruising or bleeding, 
• urinating more than usual,
• depression, and
• swelling in your hands or feet,
• aggression, 
• unusual weakness,
• weight loss or gain,
• redness or swelling of or around your eyes,
• influenza,
• high or low blood pressure.

The following drugs are related to Namenda XR, either as a replacement or used together:

• Adlarity (donepezil hydrochloride)
• Aduhelm (aducanumab)
• Amyvid (florbetapir f 18 injection)
• Aricept (donepezil)
• Axona (caprylidene prescription medical food)
• Cognex (tacrine)
• Exelon (rivastigmine tartrate)
• Neuraceq (florbetaben f 18 injection)
• Tauvid (flortaucipir f 1 injection, for intravenous use)
• Vizamyl (flutemetamol f 18 injection)
• Razadyne (galantamine hbr)
• Namenda (memantine hcl)
• Namzaric (memantine hydrochloride extended-release and donepezil hydrochloride capsules)
• Zyprexa (olanzapine)
• Zyprexa Relprevv (olanzapine extended release injectable suspension)
• Risperdal (risperidone)
• Risperdal Consta (risperidone)